Joint Postdoctoral Fellowship– TIGEM & SR-Tiget, Italy

Post-doctoral Position in Italy

Joint Postdoctoral Fellowship: Fondazione Telethon invites early-career scientists to apply for its prestigious Joint Postdoctoral Program at two world-leading institutes in Italy: TIGEM (Telethon Institute of Genetics and Medicine) in Pozzuoli and SR-Tiget (San Raffaele Institute of Gene Therapy) in Milan. This competitive 3-year fellowship is designed for highly motivated PhD holders aiming to advance their careers in genetic medicine and gene therapy. The program offers access to exceptional research environments, cutting-edge technologies, and interdisciplinary collaborations within globally recognized institutions.

Joint Postdoctoral Fellowship in Genetic Medicine and Gene Therapy – TIGEM & SR-Tiget, Italy


Summary Table:

CategoryDetails
DesignationPostdoctoral Fellow
Research AreaGenetic Medicine, Gene Therapy, Cell Biology, Molecular Biology
LocationsTIGEM (Pozzuoli) and SR-Tiget (Milan), Italy
Eligibility/QualificationPhD in Life Sciences or related fields; up to 4 years postdoc experience
Fellowship Duration3 years
Application DeadlineOctober 30, 2025
Preferred BackgroundScientists currently working outside Italy (priority to US-based applicants)

Designation:

Postdoctoral Fellow


Research Area:

  • Genetic Medicine
  • Gene and Cell Therapy
  • Molecular Biology
  • Genomics and Transcriptomics
  • Immunology and Cancer Biology

Location:


Eligibility/Qualification:

  • PhD in Life Sciences or closely related fields (or near completion).
  • Up to 4 years of postdoctoral experience (excluding up to 18 months of parental leave).
  • Must have resided and worked outside Italy in the past 3 years.
  • At least one first-author publication in a peer-reviewed international journal (predatory journals not accepted).
  • Strong motivation for collaborative and interdisciplinary research.
  • Excellent communication and teamwork skills.
  • Preference will be given to applicants currently based in the USA.

Job Description:

Selected candidates will:

  • Engage in high-impact research projects within interdisciplinary environments at TIGEM or SR-Tiget.
  • Have access to advanced research facilities including:
    • Genomics, spatial transcriptomics, microscopy, flow cytometry, proteomics
    • Animal models and clinical translation platforms
  • Receive career development support including:
    • Annual travel allowance (€3,000)
    • Structured training in grant writing, research management, and translational science
    • Opportunities for networking and collaboration with industry and clinical units
  • Work in a supportive and internationally diverse environment with integration opportunities between basic and clinical research.

Benefits:

  • Competitive salary based on seniority
  • Relocation support (visa, residence permit, healthcare registration, language training)
  • Welfare scheme and access to the Italian National Health System
  • Tax incentives for researchers relocating or returning to Italy
  • Work-life balance solutions, including:
    • Flexible working hours
    • Remote working options
    • On-campus nursery (discounted)
    • 5-month fully paid maternity leave

How to Apply:

Send the following documents:

  • Cover Letter (max 2 pages) outlining research background, motivations, and preferred research groups (up to 3)
  • CV
  • Contact details of 2 referees, including current supervisor

Submit applications to:

  • For TIGEM: scientific_office@tigem.it
  • For SR-Tiget: researchoffice.tiget@hsr.it

Last Date to Apply:
October 30, 2025
Early applications are encouraged. Interviews may be held online or in-person and will include a seminar and discussions with Group Leaders.


About the Host Institutes:

TIGEM – A leading research institute focusing on the biology and treatment of genetic diseases, with excellence in lysosomal biology, autophagy, and AAV gene therapy development.

SR-Tiget – A globally recognized center for cell and gene therapy, pioneering in vector design, stem cell research, and clinical gene therapy, with two approved therapies and over 150 patients treated.


For more information, visit:
🌐 www.tigem.it
🌐 www.sr-tiget.it

Link

LEAVE A REPLY

Please enter your comment!
Please enter your name here